|
|
Volumn 92, Issue 12, 2000, Pages 964-967
|
|
Avalanche of direct-to-consumer drug marketing brings new questions.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ERYTHROPOIETIN;
PROSTATE SPECIFIC ANTIGEN;
ANXIETY;
ARTICLE;
BLOOD;
DRUG INDUSTRY;
ECONOMICS;
FATIGUE;
FINANCIAL MANAGEMENT;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LABORATORY DIAGNOSIS;
MASS SCREENING;
METHODOLOGY;
NEOPLASM;
SAFETY;
STANDARD;
UNITED STATES;
VAGINA SMEAR;
ANXIETY;
CONSUMER PRODUCT SAFETY;
DRUG INDUSTRY;
ERYTHROPOIETIN;
FALSE POSITIVE REACTIONS;
FATIGUE;
HUMANS;
MARKETING OF HEALTH SERVICES;
MASS SCREENING;
NEOPLASMS;
PROSTATE-SPECIFIC ANTIGEN;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
VAGINAL SMEARS;
MLCS;
MLOWN;
|
|
EID: 0034697596
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/92.12.964 Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
